1. Early tumor shrinkage in metastatic colorectal cancer: Retrospective analysis from an irinotecan‐based randomized first‐line trial. Issue 6 (15th April 2013) Authors: Giessen, Clemens; Laubender, Ruediger P.; Fischer von Weikersthal, Ludwig; Schalhorn, Andreas; Modest, Dominik P.; Stintzing, Sebastian; Haas, Michael; Mansmann, Ulrich R.; Heinemann, Volker Journal: Cancer science Issue: Volume 104:Issue 6(2013:Jun.) Page Start: 718 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: An analysis of the German AIO KRK 0104 trial. (June 2013) Authors: Modest, Dominik P.; Laubender, Ruediger P.; Stintzing, Sebastian; Giessen, Clemens; Schulz, Christoph; Haas, Michael; Mansmann, Ulrich; Heinemann, Volker Journal: Acta oncologica Issue: Volume 52:Number 5(2013) Page Start: 956 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of KRAS exon 2 mutations on antitumor activity of afatinib and gefitinib. Issue 4 (April 2015) Authors: Gamba, Sebastian; Camaj, Peter; Heinemann, Volker; Laubender, Rüdiger P.; Wang, Yan; Zhao, Yue; Stintzing, Sebastian; Giessen, Clemens; Boeck, Stefan; Haertl, Christoph; Bruns, Christiane J.; Modest, Dominik P. Journal: Anti-cancer drugs Issue: Volume 26:Issue 4(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Effect of KRAS exon 2 mutations on antitumor activity of afatinib and gefitinib. Issue 4 (April 2015) Authors: Gamba, Sebastian; Camaj, Peter; Heinemann, Volker; Laubender, Rüdiger P.; Wang, Yan; Zhao, Yue; Stintzing, Sebastian; Giessen, Clemens; Boeck, Stefan; Haertl, Christoph; Bruns, Christiane J.; Modest, Dominik P. Journal: Anti-cancer drugs Issue: Volume 26:Issue 4(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma—Very good response predominantly in patients with intestinal type tumors. Issue 3 (25th February 2015) Authors: Schulz, Christoph; Kullmann, Frank; Kunzmann, Volker; Fuchs, Martin; Geissler, Michael; Vehling‐Kaiser, Ursula; Stauder, Heribert; Wein, Axel; Al‐Batran, Salah‐Eddin; Kubin, Thomas; Schäfer, Claus; Stintzing, Sebastian; Giessen, Clemens; Modest, Dominik Paul; Ridwelski, Karsten; Heinemann, Volker Journal: International journal of cancer Issue: Volume 137:Issue 3(2015:Aug. 01) Page Start: 678 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Predictors of EGF receptor monoclonal antibody activity in metastatic colorectal cancer: current status. (October 2012) Authors: Modest, Dominik Paul; Giessen, Clemens; Stintzing, Sebastian Journal: Colorectal cancer Issue: Volume 1:Number 5(2012) Page Start: 423 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Primary effusion lymphoma (PEL) without effusion: a patient case report of a PEL solid variant. Issue 2 (19th October 2011) Authors: Giessen, Clemens; Di Gioia, Dorit; Huber, Bruno; Seppi, Bettina; Graser, Anno; Duerr, Hans Roland; Mayr, Doris; Kirchner, Thomas; Rosenwald, Andreas; Forstpointner, Roswitha; Heinemann, Volker; Bogner, Johannes R; Ostermann, Helmut Journal: Journal of clinical pathology Issue: Volume 65:Issue 2(2012) Page Start: 189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Prognostic value of cetuximab‐related skin toxicity in metastatic colorectal cancer patients and its correlation with parameters of the epidermal growth factor receptor signal transduction pathway: Results from a randomized trial of the GERMAN AIO CRC Study Group. Issue 1 (26th June 2012) Authors: Stintzing, Sebastian; Kapaun, Christine; Laubender, Rüdiger Paul; Jung, Andreas; Neumann, Jens; Modest, Dominik Paul; Giessen, Clemens; Moosmann, Nicolas; Wollenberg, Andreas; Kirchner, Thomas; Heinemann, Volker Journal: International journal of cancer Issue: Volume 132:Issue 1(2013:Jan. 01) Page Start: 236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Surrogate endpoints in second-line treatment for mCRC: A systematic literature-based analysis from 23 randomised trials. (February 2015) Authors: Giessen, Clemens; Laubender, Ruediger Paul; Ankerst, Donna Pauler; Stintzing, Sebastian; Modest, Dominik Paul; Schulz, Christoph; Mansmann, Ulrich; Heinemann, Volker Journal: Acta oncologica Issue: Volume 54:Number 2(2015) Page Start: 187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗